Marguérite Mascha Mensonides-Harsema

Title: Marguérite Mascha Mensonides-Harsema: Innovator in Pharmaceutical Composition

Introduction

Marguérite Mascha Mensonides-Harsema is a notable inventor based in Houston, TX (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of autoimmune diseases. With a total of 2 patents, her work has the potential to impact many lives.

Latest Patents

Her latest patents include a pharmaceutical composition comprising a combination of methotrexate and novobiocin, which is aimed at the therapy of autoimmune diseases. This invention relates to a pharmaceutical product that includes therapeutic amounts of methotrexate and non-therapeutic amounts of novobiocin, along with suitable excipients. The second patent focuses on prodrugs of sulfasalazine and their pharmaceutical compositions, which are designed for the treatment of various autoimmune diseases, including rheumatoid arthritis and inflammatory bowel diseases.

Career Highlights

Throughout her career, Marguérite has worked with several companies, including Amplio Pharma AB and Truly Translational Sweden AB. Her expertise in pharmaceutical development has been instrumental in advancing therapeutic options for patients suffering from autoimmune conditions.

Collaborations

Marguérite has collaborated with notable professionals in her field, including Charlott Brunmark and Karin Von Wachenfeldt. These partnerships have further enriched her research and development efforts.

Conclusion

Marguérite Mascha Mensonides-Harsema stands out as an innovative inventor in the pharmaceutical industry. Her contributions to the treatment of autoimmune diseases through her patents reflect her commitment to improving healthcare outcomes.